Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia (original) (raw)

References

1. Coustan-Smith E, Behm FG, Sanchez J, Boyett JM, Hancock ML, Raimondi SC, Rubnitz JE, Rivera GK, Sandlund JT, Pui CH, Campana D . Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia Lancet 1998 351: 550–554
   CAS PubMed Google Scholar
2. Cave H, van der Werff ten Bosch, Suciu S, Guidal C, Waterkeyn C, Otten J, Bakkus M, Thielemans K, Grandchamp B, Vilmer E . Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer – Childhood Leukemia Cooperative Group New Engl J Med 1998 339: 591–598
   CAS PubMed Google Scholar
3. van Dongen JJM, Seriu T, Panzer-Grumayer ER, Biondi A, Pongers-Willemse MJ, Corral L, Stolz F, Schrappe M, Masera G, Kamps WA, Gadner H, van Wering ER, Ludwig WD, Basso G, De Bruijn MA, Cazzaniga G, Hettinger K, van der Does-van den Berg A, Hop WC, Riehm H, Bartram CR . Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood Lancet 1998 352: 1731–1738
   CAS Google Scholar
4. Gruhn B, Hongeng S, Yi H, Hancock ML, Rubnitz JE, Neale GA, Kitchingman GR . Minimal residual disease after intensive induction therapy in childhood acute lymphoblastic leukemia predicts outcome Leukemia 1998 12: 675–681
   CAS PubMed Google Scholar
5. van Dongen JJ, Szczepanski T, De Bruijn MA, van den Beemd MW, de Bruin-Versteeg S, Wijkhuijs JM, Tibbe GJ, van Gastel-Mol EJ, Groeneveld K, Hooijkaas H . Detection of minimal residual disease in acute leukemia patients Cytokines Mol Ther 1996 2: 121–133
   CAS PubMed Google Scholar
6. Seriu T, Hansen-Hagge TE, Erz DH, Bartram CR . Improved detection of minimal residual leukemia through modifications of polymerase chain reaction analyses based on clonospecific T cell receptor junctions Leukemia 1995 9: 316–320
   CAS PubMed Google Scholar
7. Steenbergen EJ, Verhagen OJ, van Leeuwen EF, van den Berg H, Behrendt H, von dem Borne AE, van der Schoot CE . IgH/TCR delta PCR oligonucleotide liquid hybridization, a fast and sensitive assay for monitoring minimal residual disease in childhood B-precursor ALL Leukemia 1995 9: 216–222
   CAS PubMed Google Scholar
8. Pongers-Willemse MJ, Seriu T, Stolz F, d'Aniello E, Gameiro P, Pisa P, Gonzalez M, Bartram CR, Panzer-Grumayer ER, Biondi A, San Miguel JF, van Dongen JJM . Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia Leukemia 1999 13: 110–118
   CAS PubMed Google Scholar
9. Szczepanski T, Langerak AW, Wolvers-Tettero ILM, Ossenkoppele GJ, Verhoef G, Stul M, Petersen EJ, de Bruijn MAC, van't Veer MB, van Dongen JJM . Immunoglobulin and T cell receptor gene rearrangement patterns in acute lymphoblastic leukemia are less mature in adults than in children: implications for selection of PCR targets for detection of minimal residual disease Leukemia 1998 12: 1081–1088
   CAS Google Scholar
10. Szczepanski T, Beishuizen A, Pongers-Willemse MJ, Hählen K, van Wering ER, Wijkhuijs JM, Tibbe GJM, De Bruijn MAC, van Dongen JJM . Cross-lineage T-cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B-acute lymphoblastic leukemias: alternative PCR targets for detection of minimal residual disease Leukemia 1999 13: 196–205
    CAS PubMed Google Scholar
11. Cross NC . Quantitative PCR techniques and applications Br J Haematol 1995 89: 693–697
    CAS PubMed Google Scholar
12. Cave H, Guidal C, Rohrlich P, Delfau MH, Broyart A, Lescoeur B, Rahimy C, Fenneteau O, Monplaisir N, d'Auriol L . Prospective monitoring and quantitation of residual blasts in childhood acute lymphoblastic leukemia by polymerase chain reaction study of delta and gamma T-cell receptor genes Blood 1994 83: 1892–1902
    CAS PubMed Google Scholar
13. Sykes PJ, Neoh SH, Brisco MJ, Hughes E, Condon J, Morley AA . Quantitation of targets for PCR by use of limiting dilution Biotechniques 1992 13: 444–449
    CAS PubMed Google Scholar
14. Ouspenskaia MV, Johnston DA, Roberts WM, Estrov Z, Zipf TF . Accurate quantitation of residual B-precursor acute lymphoblastic leukemia by limiting dilution and a PCR-based detection system: a description of the method and the principles involved Leukemia 1995 9: 321–328
    CAS PubMed Google Scholar
15. Neale GAM, Coustan Smith E, Pan Q, Chen X, Gruhn B, Stow P, Behm FG, Pui CH, Campana D . Tandem application of flow cytometry and polymerase chain reaction for comprehensive detection of minimal residual disease in childhood acute lymphoblastic leukemia Leukemia 1999 13: 1221–1226
    CAS Google Scholar
16. Heid CA, Stevens J, Livak KJ, Williams PM . Real time quantitative PCR Genome Res 1996 6: 986–994
    CAS PubMed Google Scholar
17. Holland PM, Abramson RD, Watson R, Gelfand DH . Detection of specific polymerase chain reaction product by utilizing the 5′–3′ exonuclease activity of Thermus aquaticus DNA polymerase Proc Natl Acad Sci USA 1991 88: 7276–7280
    CAS PubMed Google Scholar
18. Pongers-Willemse MJ, Verhagen OJ, Tibbe GJ, Wijkhuijs AJ, de Haas V, Roovers E, van der Schoot CE, van Dongen JJM . Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes Leukemia 1998 12: 2006–2014
    CAS PubMed Google Scholar
19. Mensink E, van de Locht A, Schattenberg A, Linders E, Schaap N, Geurts vK, De Witte T . Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real-time quantitative RT-PCR Br J Haematol 1998 102: 768–774
    CAS PubMed Google Scholar
20. Luthra R, McBride JA, Cabanillas F, Sarris A . Novel 5′ exonuclease-based real-time PCR assay for the detection of t(14;18)(q32;q21) in patients with follicular lymphoma Am J Pathol 1998 153: 63–68
    CAS PubMed Google Scholar
21. Marcucci G, Livak KJ, Bi W, Strout MP, Bloomfield CD, Caligiuri MA . Detection of minimal residual disease in patients with AML1/ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay Leukemia 1998 12: 1482–1489
    CAS PubMed Google Scholar
22. Pallisgaard N, Clausen N, Schroder H, Hokland P . Rapid and sensitive minimal residual disease detection in acute leukemia by quantitative real-time RT-PCR exemplified by t(12;21) TEL-AML1 fusion transcript Genes Chromosomes Cancer 1999 26: 355–365
    CAS PubMed Google Scholar
23. Emig M, Saussele S, Wittor H, Weisser A, Reiter A, Willer A, Berger U, Hehlmann R, Cross NC, Hochhaus A . Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR Leukemia 1999 13: 1825–1832
    CAS Google Scholar
24. Verhagen OJHM, Wijkhuijs AJM, van der Sluijs-Gelling AJ, Szczepanski T, van der Linden-Schrever BEM, Pongers-Willemse MJ, van Wering ER, van Dongen JJM, van der Schoot CE . Suitable DNA isolation method for the detection of minimal residual disease by PCR techniques Leukemia 1999 13: 1298–1299
    CAS PubMed Google Scholar
25. van Dongen JJM, Wolvers-Tettero IL . Analysis of immunoglobulin and T cell receptor genes. Part I: Basic and technical aspects Clin Chim Acta 1991 198: 1–91
    CAS PubMed Google Scholar
26. Beishuizen A, Verhoeven M-AJ, Mol EJ, Breit TM, Wolvers-Tettero ILM, Van Dongen JJM . Detection of immunoglobulin heavy-chain gene rearrangements by Southern blot analysis. Recommendations for optimal results Leukemia 1993 7: 2045–2053
    CAS Google Scholar
27. Steenbergen EJ, Verhagen OJ, van den Berg H, van Leeuwen EF, Behrendt H, Slater RR, von dem Borne AE, van der Schoot CE . Rearrangement status of the malignant cell determines type of secondary IgH rearrangement (V-replacement or V to DJ joining) in childhood B precursor acute lymphoblastic leukemia Leukemia 1997 11: 1258–1265
    CAS PubMed Google Scholar
28. Szczepanski T, Pongers-Willemse MJ, Langerak AW, Harts WA, Wijkhuijs AJM, van Wering ER, van Dongen JJM . Ig heavy chain gene rearrangements in T-cell acute lymphoblastic leukemia exhibit predominant DH6–19 and DH7–27 gene usage, can result in complete V–D–J rearrangements. and are rare in T-cell receptor αβ lineage Blood 1999 93: 4079–4085
    CAS PubMed Google Scholar
29. Willems PMW, Verhagen OJHM, Segeren C, Veenhuizen P, Guikema J, Wiemer E, Groothuis L, de Jong T, Kok H, Bloem A, Bos N, Vellenga E, Mensink EJBM, Sonneveld P, Lokhorst H, van der Schoot CE, Raymakers RAP . A consensus strategy to quantitate malignant cells in Myeloma patients validated in a multicentre study Blood (in press)
30. Cook GP, Tomlinson IM . The human immunoglobulin VH repertoire Immunol Today 1995 16: 237–242
    CAS Google Scholar
31. Tomlinson IM, Cook GP, Walter G, Carter NP, Riethman H, Buluwela L, Rabbitts TH, Winter G . A complete map of the human immunoglobulin VH locus Ann NY Acad Sci 1995 764: 43–46
    CAS PubMed Google Scholar
32. Corbett SJ, Tomlinson IM, Sonnhammer ELL, Buck D, Winter G . Sequence of the human immunoglobulin diversity (D) segment locus: a systematic analysis provides no evidence for the use of DIR segments, inverted D segments, ‘minor’ D segments or D–D recombination J Mol Biol 1997 270: 587–597
    CAS PubMed Google Scholar
33. Steenbergen EJ, Verhagen OJ, van Leeuwen EF, von dem Borne AE, van der Schoot CE . Distinct ongoing Ig heavy chain rearrangement processes in childhood B-precursor acute lymphoblastic leukemia Blood 1993 82: 581–589
    CAS Google Scholar
34. Beishuizen A, Verhoeven MA, van Wering ER, Hahlen K, Hooijkaas H, van Dongen JJM . Analysis of Ig and T-cell receptor genes in 40 childhood acute lymphoblastic leukemias at diagnosis and subsequent relapse: implications for the detection of minimal residual disease by polymerase chain reaction analysis Blood 1994 83: 2238–2247
    CAS Google Scholar
35. Steward CG, Goulden NJ, Katz F, Baines D, Martin PG, Langlands K, Potter MN, Chessells JM, Oakhill A . A polymerase chain reaction study of the stability of Ig heavy-chain and T-cell receptor delta gene rearrangements between presentation and relapse of childhood B-lineage acute lymphoblastic leukemia Blood 1994 83: 1355–1362
    CAS Google Scholar
36. Sanz I . Multiple mechanisms participate in the generation of diversity of human H chain CDR3 regions J Immunol 1991 147: 1720–1729
    CAS PubMed Google Scholar
37. Wasserman R, Galili N, Ito Y, Reichard BA, Shane S, Rovera G . Predominance of fetal type DJH joining in young children with B precursor lymphoblastic leukemia as evidence for an in utero transforming event J Exp Med 1992 176: 1577–1581
    CAS PubMed Google Scholar
38. Yamada M, Wasserman R, Reichard BA, Shane S, Caton AJ, Rovera G . Preferential utilization of specific immunoglobulin heavy chain diversity and joining segments in adult human peripheral blood B lymphocytes J Exp Med 1991 173: 395–407
    CAS PubMed Google Scholar
39. Steenbergen EJ, Verhagen OJ, van Leeuwen EF, Behrendt H, Merle PA, Wester MR, von dem Borne AE, van der Schoot CE . B precursor acute lymphoblastic leukemia third complementarity-determining regions predominantly represent an unbiased recombination repertoire: leukemic transformation frequently occurs in fetal life Eur J Immunol 1994 24: 900–908
    CAS PubMed Google Scholar

Download references